Therapy News and Research

RSS

VIB-KU Leuven scientists identify new mechanism that impacts cancer growth

Scientists at VIB-KU Leuven have identified a new mechanism that impacts tumor growth. The typical lack of oxygen in tumors doesn't only stimulate proliferation, but also offsets the important role of the protein PHD2 as 'cancer cell killer'.

14 Feb 2017

Salk professor receives inaugural Sjöberg Prize for groundbreaking cancer research

Salk Professor Tony Hunter, who holds an American Cancer Society Professorship, has been awarded $500,000 as part of the $1 million Royal Swedish Academy of Sciences' inaugural Sjöberg Prize for Cancer Research for "groundbreaking studies of cellular processes that have led to the development of new and effective cancer drugs."

14 Feb 2017

New infusion therapy may help avoid debilitating symptoms in Parkinson's disease patients

Constant infusion of a drug now used intermittently to "rescue" patients with Parkinson's from bouts of immobility may also help avoid these debilitating symptoms and smooth out their movement throughout the day, physician-scientists say.

14 Feb 2017

Review shows lipid nanoparticles as highly promising delivery systems in gene therapy

Lipid nanoparticles (SLNs and NLCs) are regarded as highly promising systems for delivering nucleic acids in gene therapy.

14 Feb 2017

TSRI scientists receive $3.3 million NIH grant to create new breast cancer treatments

A pair of scientists from the Florida campus of The Scripps Research Institute have been awarded up to $3.3 million from the National Cancer Institute of the National Institutes of Health to create the next generation of breast cancer treatments for the thousands of patients whose current treatment options are limited.

14 Feb 2017

New ASTRO guideline underscores safety, effectiveness of palliative radiation therapy for bone metastases

The American Society for Radiation Oncology recently published an updated clinical guideline that underscores the safety and effectiveness of palliative radiation therapy (RT) for treating painful bone metastases.

14 Feb 2017

Scientists managed to produce large quantities of promising natural substance

Once they can synthesise molecules of active natural substances, scientists will be able to harness nature’s medicine cabinet for the drugs of the future.

14 Feb 2017

Oesophageal cancer patients who suffer sarcopenia have lower chances of survival, study finds

Oesophageal cancer patients who suffer loss of muscle mass (sarcopenia) during neoadjuvant therapy (chemotherapy prior to surgery) survive, on average, 32 months less than patients with no sarcopenia.

14 Feb 2017

New RNAi treatment safely blocks ocular inflammation in mice

Scientists have developed a new RNA interference therapeutic agent that safely blocked ocular inflammation in mice, potentially making it a new treatment for human uveitis and diabetic retinopathy.

14 Feb 2017

UT professor and burn survivor develops new mobile phone app to support burn patients

Burn patients need support to transition to burn survivors. That's why Thereasa Abrams, an assistant professor in the University of Tennessee, Knoxville's College of Social Work and a burn survivor herself, has developed an app called the Bridge to help them heal faster.

14 Feb 2017

Taking prostate cancer drug with low-fat breakfast can be effective and less expensive, study finds

Taking one-fourth the standard dose of a widely used drug for prostate cancer with a low-fat breakfast can be as effective - and four times less expensive - as taking the standard dose as recommended: on an empty stomach.

14 Feb 2017

Plant-based drug for hemophilia shows promise in animal models

People with hemophilia require regular infusions of clotting factor to prevent them from experiencing uncontrolled bleeding. But a significant fraction develop antibodies against the clotting factor, essentially experiencing an allergic reaction to the very treatment that can prolong their lives.

13 Feb 2017

Long-term use of testosterone therapy in hypogonadal men may reduce risk of death from CV disease

Despite the continued controversy surrounding the use of testosterone in men who have testosterone deficiency (hypogonadism), a new study has found that long-term use of testosterone therapy not only improves vigor and vitality, but may reduce the risk of death due to cardiovascular (CV) disease.

13 Feb 2017

Researchers develop new antiviral strategy to combat respiratory syncytial virus

Researchers from VIB, UGent, the Geisel School of Medicine at Dartmouth and several collaborators developed a new antiviral strategy to fight human respiratory syncytial virus (RSV), a leading cause of lower respiratory tract infections in children.

13 Feb 2017

New study examines print quality of different composite 3D-printed bone scaffolds

A new study of bone formation from stem cells seeded on 3D-printed bioactive scaffolds combined with different mineral additives showed that some of the scaffold mineral composites induced bone-forming activity better than others.

13 Feb 2017

Cardiac resynchronisation therapy defibrillator devices released by Boston Scientific

Boston Scientific Europe announced the launch of the RESONATE™ cardiac resynchronisation therapy defibrillator (CRT-D) systems in Europe, a new family of devices featuring SmartCRT technology, which recently received CE Mark and are now available for heart failure patients across Europe.

13 Feb 2017

Therapy News and Research

VIB-KU Leuven scientists identify new mechanism that impacts cancer growth

Salk professor receives inaugural Sjöberg Prize for groundbreaking cancer research

New infusion therapy may help avoid debilitating symptoms in Parkinson's disease patients

Review shows lipid nanoparticles as highly promising delivery systems in gene therapy

TSRI scientists receive $3.3 million NIH grant to create new breast cancer treatments

New ASTRO guideline underscores safety, effectiveness of palliative radiation therapy for bone metastases

Scientists managed to produce large quantities of promising natural substance

Oesophageal cancer patients who suffer sarcopenia have lower chances of survival, study finds

New RNAi treatment safely blocks ocular inflammation in mice

UT professor and burn survivor develops new mobile phone app to support burn patients

Taking prostate cancer drug with low-fat breakfast can be effective and less expensive, study finds

Plant-based drug for hemophilia shows promise in animal models

Long-term use of testosterone therapy in hypogonadal men may reduce risk of death from CV disease

Researchers develop new antiviral strategy to combat respiratory syncytial virus

New study examines print quality of different composite 3D-printed bone scaffolds

Cardiac resynchronisation therapy defibrillator devices released by Boston Scientific

Scientists generate new insights into intricate molecular underpinnings of ubiquitin signaling

Professor aims to develop shortcuts for targeted and effective cancer therapy

Reprogramming liver cells to become pancreatic cells may help diabetic patients

New drug discovered in zebrafish model of pediatric epilepsy shows promising results in clinical study

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News